Validation of the albumin-indocyanine green evaluation model in patients with resected hepatocellular carcinoma and comparison with the albumin-bilirubin score.


Journal

Journal of hepato-biliary-pancreatic sciences
ISSN: 1868-6982
Titre abrégé: J Hepatobiliary Pancreat Sci
Pays: Japan
ID NLM: 101528587

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 12 12 2018
medline: 30 4 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

The albumin-indocyanine green evaluation (ALICE) model based on serum albumin and indocyanine retention rate has been shown to be an effective method for predicting postoperative outcomes in hepatocellular carcinoma patients. Aim of the study was to validate the ALICE model in a large Western cohort of patients by comparing the albumin-bilirubin (ALBI) score and Child-Turcotte-Pugh (CTP) score. A total of 400 patients who underwent hepatic resection from January 2005 to June 2016 at three centers were enrolled. The ALICE, ALBI, and CTP scores were computed for all patients. The ALICE score correlated better with ALBI (r = 0.428) than with CTP score (r = 0.302). Both the ALICE (grade 1: 49%; grade 2: 51%) and the ALBI (grade 1: 52.5%; grade 2: 47.5%) scores stratified the CTP class A patients into two distinct classes. The incidence of ascites (grades 1-3: ALICE 11%, 20%, 58%; ALBI 11%, 23%, 50%) and severe liver failure (ALICE 8.7%, 10.5%, 41.7%; ALBI 8.6%, 12%, 50%) increased with increasing ALBI and ALICE grade and were similar for the same grade. The ALICE model can assess hepatic functional reserve and predict postoperative outcomes with efficacy comparable with the ALBI grade and better than the CTP score.

Sections du résumé

BACKGROUND BACKGROUND
The albumin-indocyanine green evaluation (ALICE) model based on serum albumin and indocyanine retention rate has been shown to be an effective method for predicting postoperative outcomes in hepatocellular carcinoma patients. Aim of the study was to validate the ALICE model in a large Western cohort of patients by comparing the albumin-bilirubin (ALBI) score and Child-Turcotte-Pugh (CTP) score.
METHODS METHODS
A total of 400 patients who underwent hepatic resection from January 2005 to June 2016 at three centers were enrolled. The ALICE, ALBI, and CTP scores were computed for all patients.
RESULTS RESULTS
The ALICE score correlated better with ALBI (r = 0.428) than with CTP score (r = 0.302). Both the ALICE (grade 1: 49%; grade 2: 51%) and the ALBI (grade 1: 52.5%; grade 2: 47.5%) scores stratified the CTP class A patients into two distinct classes. The incidence of ascites (grades 1-3: ALICE 11%, 20%, 58%; ALBI 11%, 23%, 50%) and severe liver failure (ALICE 8.7%, 10.5%, 41.7%; ALBI 8.6%, 12%, 50%) increased with increasing ALBI and ALICE grade and were similar for the same grade.
CONCLUSIONS CONCLUSIONS
The ALICE model can assess hepatic functional reserve and predict postoperative outcomes with efficacy comparable with the ALBI grade and better than the CTP score.

Identifiants

pubmed: 30537424
doi: 10.1002/jhbp.597
doi:

Substances chimiques

Serum Albumin 0
Indocyanine Green IX6J1063HV
Bilirubin RFM9X3LJ49

Types de publication

Comparative Study Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-57

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Auteurs

Nadia Russolillo (N)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Fabio Forchino (F)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Simone Conci (S)

General and Hepatobiliary Surgery, Department of Surgery, University of Verona School of Medicine, Verona, Italy.

Caterina Mele (C)

Unit of Hepato-Biliary Surgery, Foundation "Policlinico Universitario A. Gemelli", Università Cattolica del Sacro Cuore, Rome, Italy.

Serena Langella (S)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Andrea Ruzzenente (A)

General and Hepatobiliary Surgery, Department of Surgery, University of Verona School of Medicine, Verona, Italy.

Iolanda Scoleri (I)

Unit of Hepato-Biliary Surgery, Foundation "Policlinico Universitario A. Gemelli", Università Cattolica del Sacro Cuore, Rome, Italy.

Felice Giuliante (F)

Unit of Hepato-Biliary Surgery, Foundation "Policlinico Universitario A. Gemelli", Università Cattolica del Sacro Cuore, Rome, Italy.

Alfredo Guglielmi (A)

General and Hepatobiliary Surgery, Department of Surgery, University of Verona School of Medicine, Verona, Italy.

Alessandro Ferrero (A)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH